Among active 13F managers last quarter, 2 opened and 3 added, while none reduced or exited; the largest holder to move was AdvisorShares Investments LLC (+63%). No open-market insider trades in the last 180 days.
Funds lean in and no leg opposes.
17 tracked 13F filers disclose a position in NEUP as of the latest SEC 13F filings, a combined $8.1M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Lynx1 Capital Management LP | 875K | $3.8M | —Held | Q2 2026 | |
| 2 | AdvisorShares Investments LLC | 253K | $1.1M | ▲+63% Added · +98K sh | Q2 2026 | |
| 3 | Vanguard Capital Management LLC | 173K | $758K | ▲+76% Added · +75K sh | Q2 2026 | |
| 4 | Shay Capital LLC | 156K | $681K | ▲+3.2% Added · +5K sh | Q2 2026 | |
| 5 | Balyasny Asset Management L.P. | 142K | $579K | ▲New +142K sh | Q1 2026 | |
| 6 | Citadel Advisors LLC | 73K | $317K | ▲+275% Added · +53K sh | Q2 2026 | |
| 7 | Geode Capital Management, LLC | 50K | $216K | ▼−4.8% Reduced · −2K sh | Q2 2026 | |
| 8 | Ikarian Capital, LLC | 47K | $207K | —Held | Q2 2026 | |
| 9 | Vanguard Fiduciary Trust Co | 34K | $148K | ▲+0.6% Added · +217 sh | Q2 2026 | |
| 10 | ADAR1 Capital Management, LLC | 30K | $122K | —Held | Q1 2026 | |
| 11 | Boothbay Fund Management, LLC | 14K | $61K | —Held | Q2 2026 | |
| 12 | Commonwealth Equity Services, LLC | 11K | $46K | ▲+0.1% Added · +15 sh | Q1 2026 | |
| 13 | Merck & Co., Inc. | 10K | $44K | —Held | Q2 2026 | |
| 14 | UBS Group AG | 2K | $9K | ▲+40% Added · +664 sh | Q1 2026 | |
| 15 | Rhumbline Advisers | 202 | $822 | —Held | Q1 2026 | |
| 16 | Morgan Stanley | 58 | $236 | —Held | Q1 2026 | |
| 17 | Caitong International Asset Management Co., Ltd | 3 | $13 | ▲New +3 sh | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 2 funds opened a new position in NEUP and 3 added to an existing one, while none reduced or exited. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Bright Minds Biosciences IncDRUG | 7 funds | $38.8M |
| Relmada Therapeutics IncRLMD | 7 funds | $34.1M |
| DBV Technologies Sa-Spon ADRDBVT | 7 funds | $31.5M |
| Annexon IncANNX | 7 funds | $28.4M |
| Eupraxia Pharmaceuticals IncEPRX | 7 funds | $20.0M |
| Neuronetics IncSTIM | 7 funds | $6.8M |
| Nvidia CorpNVDA | 6 funds | $3.1B |
| Apple IncAAPL | 6 funds | $2.7B |
| O'reilly Automotive IncORLY | 6 funds | $912.3M |
| Netflix IncNFLX | 6 funds | $711.5M |
| Abivax Sa-ADRABVX | 6 funds | $490.4M |
| Visa Inc-Class A SharesV | 6 funds | $449.7M |
Ranked by how many of NEUP's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in NEUP.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Oct 21, 2025 | Lynx1 Capital Management LP | 10% Owner | Buy (P) | 639K | $3.3M |
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 7 | 1 | – |
Insiders Form 4 open-market | 0 | 0 | $0 |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for NEUP
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/NEUP/capital-change-brief"
Use Arkolith's capital_change_brief for NEUP. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for NEUP. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.